<DOC>
	<DOC>NCT00940472</DOC>
	<brief_summary>The aim of this clinical trial is to compare the efficacy of DMMET-01 versus metformin hydrocloride on metabolic control in mexican type 2 diabetes patients without prior pharmacological treatment.</brief_summary>
	<brief_title>Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Ages eligible for study: 40 to 60 years With type 2 diabetes evolution &lt; 5 years without pharmacological treatment 1 month prior to the screening Fasting glucose = 130200 mg/dL HbA1c of 7% to 9% Blood pressure &lt; 140/80 mmHg Ability to communicate and meet the requirements of the study Signed Written Informed Consent before to conducting any study Body mass index (BMI) of 25 kg/m2 to 35 Kg/m2 Suspected or confirmed pregnancy Nursing Inability to secure the nonpregnant during the study duration Hypersensitivity to any biguanides Use of an investigational drug within 30 days prior to the screening Liver failure, heart failure, kidney failure or thyroid disease Periods of acute or chronic diarrhea or vomiting Chronic hepatic disease Total Cholesterol &gt;300 mg/dL Triglycerides &gt;400 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>monotherapy</keyword>
	<keyword>antidiabetics</keyword>
	<keyword>metformin</keyword>
</DOC>